1) refractory/relapsed acute myeloid leukemia
难治性急性髓性白血病
1.
Objective:To investigate the feasibility of FATG regimen (fludarabine, cytarabine, Topotecan + G-CSF) applied as the first line therapy in the adult patients with refractory/relapsed acute myeloid leukemia.
方法:对难治性急性髓性白血病(RAML)病人采用FATG方案(氟达拉滨、阿糖胞苷、拓扑替康+G-CSF)化疗,观察疗效及毒副作用。
2) Refractory or recurrent acute myelomatosis
难治性或复发性急性髓性白血病
4) refractory and relaps acute myelogenous leukemia
难治/复发急性髓性白血病
1.
Objective To evaluate the efficacy and untoward reaction of FLAG protocol(fludarabine,cytosine arabinoside and granulocyte colony stimulating factor) in treatment of refractory and relaps acute myelogenous leukemia To evaluate the efficacy and untoward reaction.
目的探讨FLAG方案[氟达拉滨(Flud)联合阿糖胞苷(Ara-C)和粒细胞集落刺激因子(G-CSF)]治疗难治/复发急性髓性白血病(AML)的临床疗效及不良反应。
6) refractory and relapsed AML
难治复发急性髓系白血病
1.
Methods:13 cases(17 times)with refractory and relapsed AML were treated with Fludarabine 30mg/m~2/d and Ara-c 2g/m~2/d for 5 days,and granulocyte colony stimulating factor G-CSF 300μg/d from day 0 till neutrophil recovery(ANC≥1×10~9/L).
目的观察FLAG方案(氟达拉滨、阿糖胞苷及粒细胞集落刺激因子组成)治疗难治复发急性髓系白血病的疗效、骨髓抑制时间以及不良反应。
补充资料：连续性与非连续性(见间断性与不间断性)
连续性与非连续性(见间断性与不间断性)
continuity and discontinuity
11an父ux泊g四f“山。麻以角g、.连续性与非连续性(c。nt，n琳t:nuity一)_见间断性与不间断性。and diseo红ti-
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条